VVUS: VIVUS INC. (NASDAQ) | Stock Discussion Forums

Biotech / Medical: VVUS: VIVUS INC. (NASDAQ)

Posts: 23464 | Member SubjectMarks: 85 | No Bans

SI Sentiment for VVUS: Insufficient votes accumulated

Add SubjectMark | Hide Original Post | Show Chart | Poster Summary | Share This Board

Moderated By: Frostman -- (Not Moderated) -- Started: 11/21/2002 9:41:10 AM Revision History

Vivus, Inc.: VVUS (NASDAQ)

WWW.VIVUS.COM

About VIVUS

VIVUS, Inc. is a pharmaceutical company engaged in the development
of innovative therapies for the treatment of quality-of-life disorders
in men and women, with a focus on sexual dysfunction. Current
development programs target Female Sexual Dysfunction (FSD), Erectile
Dysfunction (ED) and Premature Ejaculation (PE). The Company developed
and markets in the U.S. MUSE(R) (alprostadil) and ACTIS(R), two
innovations in the treatment of erectile dysfunction.

For further information: WWW.VIVUS.COM

Previous 10 | Next 10 | View Recent | Post Message

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Date
23464	WHY O WHY a convert??? argh.	mopgcw	-	05/16/2013 04:58 PM
23463	I added another couple slugs when she hit 10 and change again. getting heavy.	mopgcw	-	04/19/2013 11:17 AM
23462	Qsymia prescriptions shipped Month Ended January 31, 2013 16,733 Month Ende	Biotech Jim	-	04/19/2013 08:18 AM
23461	VIVUS, Inc. (Nasdaq: VVUS) announced that the U.S. Food and Drug Administration	The Ox	-	04/18/2013 10:53 AM
23460	VIVUS, Inc. (NASDAQ: VVUS) 5% LOWER; announced today that the European Medicines	mopgcw	-	02/22/2013 11:09 AM
23459	Leerink Swann Resumes Vivus (VVUS) at Outperform, $19-$20 Valuation 7:17 AM 2/	mopgcw	-	02/06/2013 07:22 PM
23458	VIVUS, Inc. (VVUS) Qsymia Prescriptions Show Gains During Slow Holiday Week (ARN	mopgcw	-	02/04/2013 07:24 PM
23457	Vivus rises on latest Qsymia prescription report 3:23 PM 1/7/2013 - AcquireMed	mopgcw	-	01/07/2013 06:56 PM
23456	From ML/BAC Vivus (VVUS) has been added to the US 1 list today. Today's c	tom pope	-	01/07/2013 10:44 AM
23455	Vivus Inc. (VVUS). The company said its obesity drug will now be covered by the	tom pope	-	12/20/2012 08:47 AM
23454	Best analysis I’ve seen of Qsymia dilemma: investorshub.advfn.com :-)	DewDiligence_on_SI	-	11/06/2012 07:02 PM

Go to reply# or date (mm/dd/yy):